Nomograms for clinically localized disease. Part III: watchful waiting.
Nomograms for clinically localized disease. Part III: watchful waiting.
复制标题
临床局部疾病的列线图。
DOI:
10.1053/suro.2002.32495
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
Albertsen,Peter
中科院分区:
文献类型:
--
作者:
Schwartz,Eric;Albertsen,Peter
Patients with newly diagnosed, clinically localized prostate cancer need information concerning long-term outcomes to make informed decisions regarding treatment options. Several nomograms have been developed that can help in this decision process. By using a nomogram originally published in 1998, patients and clinicians can predict the 15-year clinical outcomes in the absence of aggressive treatment based on age and Gleason score at diagnosis. These predictions are based on patients diagnosed and treated before the routine use of PSA that has accelerated the diagnosis of prostate cancer by at least 5 years. Longer follow-up of contemporary patients will determine whether this nomogram remains accurate in the prostate-specific antigen (PSA) era. In view of the lead-time bias resulting from PSA testing, the outcomes of contemporary patients are likely to be better rather than worse than the results shown.
登录
查看更多内容
影响因子:
14.9
作者:
J. Rogers;P. Clarke;W. Salser
通讯作者:
W. Salser
影响因子:
15.3
作者:
H. Sato;E. A. Boyse;T. Aoki;C. Iritani;L. Old
通讯作者:
L. Old
DOI:
--
发表时间:
1983
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Teale,JM
通讯作者:
Teale,JM
影响因子:
56.9
作者:
C. Liu;P. Tucker;J. Mushinski;F. Blattner
通讯作者:
F. Blattner
DOI:
10.1073/pnas.74.11.4835
发表时间:
1977-01-01
影响因子:
11.1
作者:
MCMASTER, GK;CARMICHAEL, GG
通讯作者:
CARMICHAEL, GG